Glycogen synthase kinase-3α reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases

被引:59
|
作者
Zhai, Peiyong
Gao, Shumin
Holle, Eric
Yu, Xianzhong
Yatani, Atsuko
Wagner, Thomas
Sadoshima, Junichi
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Inst Cardiovasc Res, Newark, NJ 07103 USA
[2] Oncol Res Inst, Greenville, SC USA
关键词
D O I
10.1074/jbc.M705133200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glycogen synthase kinase-3 ( GSK-3) is a serine/threonine kinase having multiple functions and consisting of two isoforms, GSK-3 alpha and GSK-3 beta. Pressure overload increases expression of GSK-3 alpha but not GSK-3 beta. Despite our wealth of knowledge about GSK-3 beta, the function of GSK-3 alpha in the heart is not well understood. To address this issue, we made cardiac-specific GSK-3 alpha transgenic mice ( Tg). Left ventricular weight and cardiac myocyte size were significantly smaller in Tg than in non-Tg ( NTg) mice, indicating that GSK-3 alpha inhibits cardiac growth. After 4 weeks of aortic banding ( transverse aortic constriction ( TAC)), increases in left ventricular weight and myocyte size were significantly smaller in Tg than in NTg, indicating that GSK-3 alpha inhibits cardiac hypertrophy. More severe cardiac dysfunction developed in Tg after TAC. Increases in fibrosis and apoptosis were greater in Tg than in NTg after TAC. Among signaling molecules screened, ERK phosphorylation was decreased in Tg. Adenovirus-mediated overexpression of GSK-3 alpha, but not GSK-3 beta, inhibited ERK in cultured cardiac myocytes. Knockdown of GSK-3 alpha increased ERK phosphorylation, an effect that was inhibited by PD98059, rottlerin, and protein kinase C epsilon ( PKC epsilon) inhibitor peptide, suggesting that GSK-3 alpha inhibits ERK through PKC-MEK-dependent mechanisms. Knockdown of GSK-3 alpha increased protein content and reduced apoptosis, effects that were abolished by PD98059, indicating that inhibition of ERK plays a major role in the modulation of cardiac growth and apoptosis by GSK-3 alpha. In conclusion, up-regulation of GSK-3 alpha inhibits cardiac growth and pressure overload-induced cardiac hypertrophy but increases fibrosis and apoptosis in the heart. The anti-hypertrophic and pro-apoptotic effect of GSK-3 alpha is mediated through inhibition of ERK.
引用
收藏
页码:33181 / 33191
页数:11
相关论文
共 50 条
  • [1] Glycogen synthase kinase-3α regulates cardiac growth and attenuates pressure overload-induced cardiac hypertrophy in transgenic mice
    Zhai, Peiyong
    Gao, Shumin
    Sadoshima, Junichi
    CIRCULATION, 2006, 114 (18) : 85 - 85
  • [2] Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload
    Yamamoto F.
    Yamamoto H.
    General Thoracic and Cardiovascular Surgery, 2010, 58 (6) : 263 - 264
  • [3] Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload
    Tateishi A.
    Matsushita M.
    Asai T.
    Masuda Z.
    Kuriyama M.
    Kanki K.
    Ishino K.
    Kawada M.
    Sano S.
    Matsui H.
    General Thoracic and Cardiovascular Surgery, 2010, 58 (6) : 265 - 270
  • [4] Extracellular signal-regulated kinase (ERK) activation preserves cardiac function in pressure overload induced hypertrophy
    Mutlak, Michael
    Schlesinger-Laufer, Michal
    Haas, Tali
    Shofti, Rona
    Ballan, Nimer
    Lewis, Yair E.
    Zuler, Mor
    Zohar, Yaniv
    Caspi, Lilac H.
    Kehat, Izhak
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 270 : 204 - 213
  • [5] Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase
    Q Wang
    Y Zhou
    X Wang
    B M Evers
    Oncogene, 2006, 25 : 43 - 50
  • [6] Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase
    Wang, Q
    Zhou, Y
    Wang, X
    Evers, BM
    ONCOGENE, 2006, 25 (01) : 43 - 50
  • [7] Assessing the role of extracellular signal-regulated kinases 1 and 2 in volume overload-induced cardiac remodelling
    Jochmann, Svenja
    Elkenani, Manar
    Mohamed, Belal A.
    Buchholz, Eric
    Lbik, Dawid
    Binder, Lutz
    Lorenz, Kristina
    Shah, Ajay M.
    Hasenfuss, Gerd
    Toischer, Karl
    Schnelle, Moritz
    ESC HEART FAILURE, 2019, 6 (05): : 1015 - 1026
  • [8] Extracellular signal-regulated kinases 1/2 as regulators of cardiac hypertrophy
    Mutlak, Michael
    Kehat, Izhak
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [9] Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3β activation
    Li, Huey-Jiun
    Yin, Hang
    Yao, Yu-Yu
    Shen, Bo
    Bader, Michael
    Chao, Lee
    Chao, Julie
    CARDIOVASCULAR RESEARCH, 2007, 73 (01) : 130 - 142
  • [10] Diacylglycerol kinase ζ attenuates pressure overload-induced cardiac hypertrophy
    Harada, Mutsuo
    Takeishi, Yasuchika
    Arimoto, Takanori
    Niizeki, Takeshi
    Kitahara, Tatsuro
    Goto, Kaoru
    Walsh, Richard A.
    Kubota, Isao
    CIRCULATION JOURNAL, 2007, 71 (02) : 276 - 282